Using mass cytometry and transcriptomic analyses, Toker and colleagues discovered that ovarian cancer Tregs exhibited increases in PD-1 and 4-1BB levels, which are associated with greater suppressive capabilities. The gene discussed is PDCD1; the disease is ovarian cancer.